The North Africa Non-Invasive Prenatal Testing (NIPT) Market is estimated to be valued at US$ 2,796 Mn in 2021 and is projected to exhibit a CAGR of 8.7% during the forecast period of 2023-2030. The rising awareness among expectant parents regarding the benefits of non-invasive prenatal testing is driving the market growth. Non-invasive prenatal testing offers advantages such as early detection ... Read more
Non-invasive prenatal testing (NIPT) offers women safer and more reliable options for prenatal screening compared to traditional screening methods. It analyzes cell-free DNA from a simple blood draw of the mother to screen for common genetic conditions like Down syndrome with high accuracy. The rising cases of pregnancies affected by chromosomal abnormalities have boosted the demand for NIPT across North Africa.
The North Africa Non-Invasive Prenatal Testing Market is estimated to be ... Read more
The North Africa non-invasive prenatal testing (NIPT) market is comprised of prenatal screening tests that analyze cell-free DNA from a maternal blood sample to screen for genetic abnormalities in a fetus. Non-invasive prenatal testing analyzes specific fetal DNA and RNA fragments found in the mother's bloodstream and provides a safer alternative to invasive tests like amniocentesis. It screens for Down syndrome, Edwards syndrome, Patau syndrome and sex chromosome abnormalities like ... Read more
